MiniMed Group, Inc. - Common Stock (MMED)
Price History
Mar 29, 2026 — Jul 6, 2026Investment Snapshot
- P/B of 0.94 — trading below book value
- Piotroski F-Score 3/9 — signs of financial weakness
- Loss-making — negative ROE of -4.2%
- Revenue growing at 14% annually
MiniMed Group, Inc. - Common Stock (MMED) is a publicly traded company, listed on the NASDAQ , with a market capitalisation of $3.4 billion . Key value metrics: P/B ratio 0.94, Piotroski F-Score 3 out of 9 .
Value Score
Key Metrics
MiniMed Group, Inc. - Common Stock — Fundamental Analysis Summary
On financial health, MMED shows a weak Piotroski F-Score of 3/9, a signal of deteriorating financial health, and negative return on equity of -4.2%.
StockPik's composite Value Score for MMED is 58/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
MMED reports a solid gross margin of 54.2% and a negative operating margin of -6.1%.
MMED shows revenue growing at 14% year-over-year, with earnings declining at 56%.